Trial intelligence / Profile preview

Soriatane Dose Reduction in Severe Plaque Psoriasis

NCT01228409Phase 4Unknown

Start
Oct 2010
Primary completion
Dec 2011
Countries
1
01

Overview

A Phase 4 trial of acitretin in plaque psoriasis. Status: unknown.

02

Drugs

acitretin
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on NCT01228409.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01228409.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call